The U.S. IV infusion products market is estimated to be valued at US$ 7,885.4 Mn in 2023 and is expected to exhibit a CAGR of 3.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
The U.S. IV infusion products market refers to the market for intravenous infusion products, including IV solutions, IV sets, and IV catheters. These products are used for delivering fluids, medications, and nutrients directly into the patient’s bloodstream. They are widely used in hospitals, clinics, and home healthcare settings. The market for IV infusion products is driven by the increasing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular diseases, which require frequent intravenous administration of medications. The market is also influenced by the rising hospitalization rates, as hospitals are major users of IV infusion products for patient care.
Ask Us to Get Your Sample Copy Of The Report, Covering TOC and Regional Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4700
The U.S. IV infusion products market is driven by two key factors: the increasing prevalence of chronic diseases and rising hospitalization rates. The growing burden of chronic diseases in the U.S. has led to an increased demand for IV infusion products, as these products are essential for the treatment and management of these diseases. Additionally, the rising hospitalization rates in the country have further fueled the demand for IV infusion products, as these products are extensively used in hospitals for various medical procedures. The market is also expected to benefit from technological advancements in IV infusion products, such as the development of advanced infusion pumps and catheters, which offer improved safety and accuracy in drug administration. Overall, the U.S. IV infusion products market is poised to experience significant growth in the coming years, driven by the increasing need for efficient and safe intravenous therapy.
Market Driver 1: Rising Prevalence of Chronic Diseases
The U.S. IV infusion products market is being driven by the rising prevalence of chronic diseases. Chronic diseases such as diabetes, cancer, and cardiovascular diseases require long-term management and often necessitate the administration of intravenous medications and fluids. As the incidence of these diseases continues to rise in the United States, so does the demand for IV infusion products.
According to the Centers for Disease Control and Prevention (CDC), chronic diseases are the leading causes of death and disability in the United States, accounting for approximately 7 out of 10 deaths each year. The CDC also estimates that 6 in 10 adults in the U.S. have at least one chronic disease, with 4 in 10 adults having two or more chronic conditions. This growing prevalence of chronic diseases is fueling the need for IV infusion products to help manage these conditions effectively.
Furthermore, advancements in medical technology and drug delivery systems have made IV infusion products more efficient and less invasive. This has led to an increased acceptance and adoption of IV infusion therapy as a preferred method of treatment for many chronic diseases. As a result, the demand for IV infusion products is expected to continue to grow in the coming years.
Market Driver 2: Aging Population
Another significant driver of the U.S. IV infusion products market is the aging population. As the baby boomer generation enters their senior years, the demand for healthcare services, including IV infusion therapy, is expected to increase. Aging is often accompanied by a higher prevalence of chronic diseases, such as arthritis, osteoporosis, and Alzheimer’s disease, which require the use of IV infusion products for management.
According to the U.S. Census Bureau, the number of Americans aged 65 and older is projected to nearly double from 52 million in 2018 to 95 million by 2060. This increase in the elderly population will result in a greater demand for healthcare services, including IV infusion therapy.
Furthermore, as people age, their ability to swallow or digest medications may decrease, making IV infusion therapy a necessary method of delivering medications and nutrients. This creates a growing market for IV infusion products designed for the elderly population.
Market Restraint 1: High Cost of IV Infusion Products
Despite the growing demand for IV infusion products, one of the major restraints for the U.S. market is the high cost associated with these products. IV infusion products can be costly, particularly when considering the price of the equipment, fluids, medications, and disposables. This can place a financial burden on both patients and healthcare facilities, limiting the adoption and use of IV infusion therapy.
Additionally, the reimbursement policies of insurance companies and Medicare often do not fully cover the costs associated with IV infusion therapy, leading to higher out-of-pocket expenses for patients. As a result, some patients may be unable to afford or may choose to forgo necessary IV infusion treatments due to financial constraints.
Market Restraint 2: Risk of Complications and Infections
Another significant restraint for the U.S. IV infusion products market is the risk of complications and infections associated with IV infusion therapy. Despite the advancements in technology and safety measures, there is always a risk of complications, such as bloodstream infections, phlebitis, infiltration, and extravasation.
These complications can lead to extended hospital stays, additional healthcare costs, and even life-threatening conditions. As a result, healthcare providers and patients need to be vigilant in monitoring for signs of complications during and after IV infusion therapy, which can create additional stress and burden on the healthcare system.
Additionally, the improper handling or lack of proper sterilization of IV infusion products can also contribute to the risk of infections. This can be a significant concern in healthcare facilities, where multiple patients may be receiving IV infusion therapy in close proximity. Efforts to improve infection prevention and control practices are essential to reduce the risk of complications and infections associated with IV infusion therapy.
Overall, while the U.S. IV infusion products market is driven by factors such as the rising prevalence of chronic diseases and the aging population, it also faces restraints such as the high cost of these products and the risk of complications and infections. Efforts to address these restraints, such as cost-effective manufacturing processes and improved safety protocols, will help to ensure the continued growth and development of the market.
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐔𝐩 𝐓𝐨 𝟐𝟓% 𝐎𝐅𝐅 @ https://www.coherentmarketinsights.com/insight/buy-now/4700
|The market size value in 2023|
Table of Contents with Major Points:
- Key Findings
- Definitions and Assumptions
- Definition of U.S. IV Infusion Products Market
- Market Dynamics
- Trends and Developments
- Key Emerging Trends
- Key Developments Mergers and Acquisition
- New Product Launches and Collaboration
- Partnership and Joint Venture
- Latest Technological Advancements
- Insights on Regulatory Scenario
- Porters Five Forces Analysis
Qualitative Insights Impact of COVID-19 on Global U.S. IV Infusion Products Market
- Supply Chain Challenges
- Steps taken by Government/Companies to overcome this impact
- Potential opportunities due to COVID-19 outbreak
- Data Sources
Why Choose Coherent Market Insights?
☛ Identified business opportunities – Our market research report can be used to analyze potential markets and new products. It can give information about customer needs, preferences, and attitudes. Also, it compare products and services.
☛ A clear understanding of your customers – A market report gives company’s marketing department an in-depth picture about customers’ needs and wants. This knowledge can be used to improve products, prices, and advertising.
☛ Clear data-driven insights – Our Market research encompasses a wide range of activities, from determining market size and segment to forecasting demand, and from identifying competitors to monitoring pricing. All of these are quantified and measurable which means that gives you a clear path for building unique decisions based on numbers.
Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/4700
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027